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Poster Session I S211At 7 years, the cumulative proportion of those receiving 2nd trans-
plants is 40% (95% CI: 23%, 61%) It should be noted that median
follow-up time for those who have not yet received a second trans-
plant is only 14 months and 75% of these pts have been followed
for 32 months or less. Thus, in a more mature database with longer
follow-up the proportion of those receiving a second transplant may
increase.
Conclusion: We need guidelines for cryopreservation of HSC for
MM pts based on prospective evaluation to best utilize stem cell lab-
oratory resources.
Table 1. Demographic and Disease Characteristics
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Race 0.35Black 3 (18%) 75 (32%)
White 14 (82%) 155 (66%)
Other 0 (–) 5 (2%)Gender 0.005
Female 2 (12%) 107 (46%)
Male 15 (88%) 128 (54%)Stage* 0.49
I 0 22 (9%)
II 8 (47%) 51 (22%)
III 9 (53%) 161 (69%)* Durie Salmon Staging SystemGRAFT PROCESSING
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FACTORS AFFECTING CD34 + CELL PURITY, CD34 + CELL RECOVERY,
AND LOG T CELL DEPLETION OF PRODUCTS PROCESSED FOR CD34-EN-
RICHMENT ON THE ISOLEX— CELL SEPARATION DEVICE. A SINGLE CEN-
TER EXPERIENCE
Keever-Taylor, C.A.1, Zhang, L.2, Konings, S.1, Skonecki, J.A.1,
Zheng, H.1, Heidtke, S.A.1 1Medical College of Wisconsin, Milwaukee,
WI; 2Emmes Corporation, Rockville, MD
CD34-enrichment is commonly used as a method for the rigorous
removal of T cells from products used for hematopoietic progenitor
cell transplantation. Published reports have consistently shown
a high level of T cell depletion (TCD) and a high degree of purity
in the CD34-enriched products. Recovery of CD34+ cells from the
starting fraction has been more variable both within and between
centers. We performed univariate (UV) and multi-variable analysis
(MV) of 106 enrichment procedures of products obtained from 59
allogeneic donors to determine factors affecting CD34+ cell recov-
ery, log TCD, and product purity. Variables assessed included: the
number and concentration of total nucleated cells (TNC) loaded
onto the column, starting mononuclear cell (MNC) content, the
number of starting CD34+ and CD3+ cells, and time from the end
of collection to the start of selection. The analysis used a mixedCD341Cell Re
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.0007 -
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.0001 0effect model to adjust for multiple observations from the same do-
nors. Factors found to be associated with better CD34+ cell recov-
ery in the UV included fewer starting TNC, loading concentration
#4.0E8 TNC/mL, and fewer starting CD34+ cells. Using back-
ward selection, in the MV only starting CD34+ cells and TNC/
mL remained independently associated with recovery. Indeed, me-
dian CD34+ cell recovery was 63.5% at the lowest quartile of
starting CD34+ cell numbers (1.1E8 -3.6E8) and fell progressively
to 56.5% (3.7E8-5.4E8), 55.0% (5.5E8-7.3E8), and 42.9% (7.5E8-
2.6E9) for the 2nd, 3rd, and 4th quartiles, respectively. The addi-
tional effect of TNC/mL was seen regardless of time from collec-
tion to start of selection and there was no association of TNC/mL
and starting or ending product viability. CD34+ cell purity was
greatest at higher starting numbers of TNC and CD34+ cells
and at lower MNC content. Here a median CD34+ cell purity
of 93.4% was seen for the lowest quartile of starting CD34+ cells
versus 98.6% for the highest quartile. Starting CD34+ cells was
the only variable affecting Log TCD (poorer TCD with more
starting CD34+ cells). In conclusion, CD34+ cell recovery using
the Isolex device can be maximized by restricting the number of
CD34+ cells loaded onto the column and by ensuring that the
TNC loaded are # 4.0E8 TNC/mL. Even though fewer starting
CD34+ cells may result in somewhat poorer final product purity,
T cell content in the final product was not increased.144
A COMPARISON OF IN-SITU CB COLLECTION: VAGINAL VS. CESAREAN
SECTION
Miller, S.1, Kuenne, S.1, Zarlengo, G.2, Stark, C.2, Quinones, R.1,
Freed, B.1 1UC Denver – ClinImmune Labs, Aurora, CO; 2Exempla
St. Joseph Hospital, Denver, CO
With a national cesarean birth rate of .30%, these deliveries
represent a significant source of umbilical cord blood. We there-
fore compared cord blood units (CBU) obtained from planned
cesarean (n5 104) and vaginal (n5 581) births at the same hos-
pital over a seven month period in 2009. In both cases, the CBU
were collected in situ, prior to delivery or removal of the pla-
centa. The cesarean collections were performed with a sterile
connecting device placed within the sterile field connected to
the CB collection bag outside the field. The mean volume and
total nucleated cell count of cesarean CBU (120 ml; 1.4  109
TNC) were 33% greater than vaginal CBU (90 ml; 0.9  109
TNC; p\0.0001). In addition, cesarean CBU had a 0% contam-
ination rate, compared to 7% for vaginal CBU. CD34+ cell
counts were only performed on those CBU that contained
.0.9  109 TNC; the post-processing CD34 counts were not
significantly different between cesarean (4.9  106) and vaginal
births (5.1  106). Deferrals for donor ineligibility and maternal
risks were only 5% in cesarean collections, compared to 11% of
vaginal cord blood donors. There were no safety issues identified
for mothers or babies with the cesarean collections. As a result of
the higher cord blood volume, lower contamination rates, and
fewer deferrals, cesarean collections resulted in a 78% increase
in banking efficiency. This study suggests that cesarean birthsDependent Variable
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